CDH1-related diffuse gastric and lobular breast cancer syndrome: genes and variants
Explore variant evidence for CDH1-related diffuse gastric and lobular breast cancer syndrome across 1 analyzed protein (CDH1). Linked ClinVar records include 11 pathogenic or likely pathogenic variants, 38 variants of uncertain significance and 15 with conflicting classifications.
Coverage includes proteins already analyzed in CATVariant, not every gene involved in this condition. Database links are associations, not an assessment of clinical gene–disease validity. Computable evidence prioritizes variants for expert review and does not reclassify them. Counts refer to the selected disease label.
Data updated 2026-10-15. Automated aggregation, not a clinical review date.
Download variant evidence (CSV)
Genes linked to CDH1-related diffuse gastric and lobular breast cancer syndrome
CDH1: Cadherin-1
Its E-cadherin-mediated adhesion preserves epithelial architecture and suppresses inappropriate cell detachment and invasion. Germline loss-of-function variants cause hereditary diffuse gastric cancer syndrome and substantially increase diffuse gastric and lobular breast-cancer risk.
11 ClinVar pathogenic / likely pathogenic and 53 uncertain variants in CDH1 have source records linked to CDH1-related diffuse gastric and lobular breast cancer syndrome. Association strength is not clinical gene validity.
ClinVar pathogenic and likely pathogenic variants linked to CDH1-related diffuse gastric and lobular breast cancer syndrome
| Variant | Position | Protein part | Clinical label |
|---|---|---|---|
| CDH1 M1K | 1 | Pathogenic / likely pathogenic (★★★) | |
| CDH1 M1T | 1 | Pathogenic / likely pathogenic (★★★) | |
| CDH1 M1R | 1 | Pathogenic / likely pathogenic (★★★) | |
| CDH1 M1I | 1 | Pathogenic / likely pathogenic (★★★) | |
| CDH1 M1V | 1 | Pathogenic / likely pathogenic (★★★) | |
| CDH1 G239R | 239 | Cadherin 1 | Pathogenic / likely pathogenic (★★★) |
| CDH1 E336D | 336 | Cadherin 2 | Pathogenic / likely pathogenic (★★★) |
| CDH1 E353K | 353 | Cadherin 2 | Pathogenic / likely pathogenic (★★★) |
| CDH1 T560R | 560 | Cadherin 4 | Pathogenic / likely pathogenic (★★★) |
| CDH1 T568R | 568 | Cadherin 4 | Pathogenic / likely pathogenic (★★★) |
| CDH1 R732Q | 732 | Cytoplasmic | Pathogenic / likely pathogenic (★★★) |
Which prediction tools work for CDH1-related diffuse gastric and lobular breast cancer syndrome
Observed separation of ClinVar pathogenic / likely pathogenic from benign / likely benign variants (AUROC × 100). This benchmark is not a clinical recommendation.
- SIFT: 90 out of 100
- AlphaMissense: 72 out of 100
- PolyPhen-2: 72 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- ESM1b (LLR): 70 out of 100
- CATVariant: 63 out of 100 (learned from overlapping clinical labels, so this is optimistic)
Same protein, different disease
- Hereditary diffuse gastric adenocarcinoma also has ClinVar records linked to CDH1 variants; they fall mostly in different places as the CDH1-related diffuse gastric and lobular breast cancer syndrome variants (4 pathogenic / likely pathogenic).
Diseases related to CDH1-related diffuse gastric and lobular breast cancer syndrome
- Developmental and epileptic encephalopathy, also linked to CDH1
- Ovarian cancer, also linked to CDH1
- Hereditary breast cancer, also linked to CDH1
- Hereditary breast ovarian cancer syndrome, also linked to CDH1
- Breast and/or ovarian cancer, also linked to CDH1
- Prostate cancer, also linked to CDH1
- Endometrial carcinoma, also linked to CDH1
- Hereditary diffuse gastric adenocarcinoma, also linked to CDH1
- Blepharocheilodontic syndrome 1, also linked to CDH1
Frequently asked questions
Which genes have records linked to CDH1-related diffuse gastric and lobular breast cancer syndrome?
This view contains 1 analyzed proteins: CDH1. Links come from clinical records and association databases. They do not imply that every listed gene is a validated cause, and missing genes may not yet be analyzed.
What do the clinical classifications mean?
Linked records include 11 pathogenic or likely pathogenic variants, 38 variants of uncertain significance and 15 with conflicting classifications. Labels summarize source records; multi-condition records may not make a separate assertion for this disease. Check the original record and review status.
Does the evidence score change a VUS classification?
No. 0 VUS or conflicting variants reach the likely-pathogenic points range on the computable criteria available here. This is a research prioritization signal, not a clinical classification. Patient, family and other required evidence may be missing.
Can I download the variant evidence?
Download the CSV for all 143 variants in the selected disease scope, including clinical labels, review status, evidence criteria, predictor scores, functional measurements and population frequency where available.
About this data
Variant–disease links come from ClinVar, Open Targets and UniProt, pooled from eligible public CATVariant analyses of each human protein. Evidence scores use the ACMG/AMP Bayesian points scale with computable criteria only (position among known disease variants, rarity in gnomAD, calibrated predictors, deep mutational scanning); there is no family or patient data, so they prioritise variants for expert review and never classify them.
Download every variant as CSV · Browse all diseases · Methods · About the Center